Home> About us> Team introduction

Zhang Guanjing

Chairman and CEO
He graduated from Tsinghua University, University of International Business and Economics MBA, Harvard Business School EMBA. His book "Huawei Four Faces" sold 2 million copies. Zhang Guanjing also won the "2017 China leading Innovation figures" and “Guangdong S&T entrepreneurship leading talent” and “China‘s outstanding entrepreneur award on the 40th anniversary of reform and opening up”, and led E-Techco Group to participate in two EU FP7 projects (Urosense and Advance) and A number of national, provincial and municipal research projects.

Harry Holthofer

Chief bioanalytical scientist
Hary Holthofer is involved in leading E-Techco team to develop projects such as Biomarker Sensor for Diagnosing Diabetes. With more than 20 years of clinical experience, he has used international leading edge bioanalytical techniques such as genomics, proteomics, metabolomics and transcriptomics to overcome the world's medical problems in the field of diabetes and complication biomarkers and sensors. He has collaborate with a number of Fortune 500 medical device companies worldwide.

Yao Jianquan Academician

Smart elderly care scientist
From 1980 to 1982, he went to Stanford University and the University of California for further studies. In 1997, he was elected as an academician of the Chinese Academy of Sciences. He won the second prize of the National Invention, the State Education Commission and the Second Prize of Tianjin Science and Technology Progress (4 times), and the first prize of the Army Science and Technology Progress Award. The Chinese Academy of Sciences special prize. Yao Jianquan has made great achievements in the field of science. He is a "National-level Young and Middle-Aged Expert with Outstanding Contributions", "National University Advanced Science and Technology Workers", "National Excellent Science and Technology Personnel", and enjoys special allowances from the State Council and participates in the guidance of AnyCheck health management platform development.

Qian Wei

AnyCheck Artificial Intelligence Institution
Professor Qian Wei is a professor at the Moffitt Cancer Research Center (ranked 10th in US), a jury member of the NIH Special Key Discipline, and the dean of the Sino-Dutch School of Biomedical and Information Engineering at Northeastern University. Professor Qian is the founder of the world's early lung cancer detection and diagnosis system, and developed the world's first computer aided diagnostic equipment for lung cancer approved by the US Food and Drug Administration (FDA). He published more than 150 SCI papers and conference articles, H-index: 31. He created MiraMedica, which was acquired by Carestream (formerly Kodak) for $50 million. He leads AnyCheck Development Cancer AI-CAD diagnostic system, working with a number of hospitals and doctors to provide medical support for graphic data and other projects.

Yao Yudong

AnyCheck Artificial Intelligence Institution
Yao Yudong is a tenured professor of the Stevens Institute of Technology, director of the Department of Electronics and Computer Engineering, IEEE Fellow, Fellow of National Academy of Inventors, and guest professor of Nanjing University of Posts and Telecommunications, distinguished professor of Northeastern University. In 2017, he was elected as the Fellow of Canadian Academy of Engineering. Academician of the Canadian Academy of Engineering is the honorary title of the Canadian federal government to represent the Canadian national level scientists in the engineering field, and as a national think tank to provide authoritative advice on project establishment, review and research at the national level, there are currently more than 300 people. He leads the design of AI-CAD diagnostic system cloud platform for lung cancer in Qianhai AnyCheck.

Zheng Bin

AnyCheck Artificial Intelligence Institution
Since 1998, Professor Zheng has led and completed five major research projects funded by the National Institutes of Health (NIH) (R01, the highest award in US individual application fund field) and an innovative research project. (R21), a New Idea research project funded by the US Department of Defense. At the same time, as the sub-project leader, he participated in the leadership of the two R01 and one UL1 research projects funded by the National Institutes of Health (NIH). The paper has published more than 300 papers, H-index: 37. Many of its research results have been adopted by internationally renowned companies such as Siemens, Philips, and General Electric. Participated in the development of the AI-CAD diagnostic system for lung cancer in Qianhai, leading the processing and analysis of image big data, and the construction of AI model.

Li Shufang Professor

Cooperative scientist
She mainly engaged in AI medical and medical big data analysis. She undertook major projects in AI medical imaging of Scientific Instruments of National Natural Science Foundation of China and National Science and Technology Major Project of the Ministry of Science and Technology of China, 863 Program and 973 Program in the field of theory and verification of IoT. She has published over 100 papers in core journals and well-known international conference, of which more than 80 SCI indexed and more than 50 patents. She cooperates with E-Techco (Qianhai AnyCheck) in medical imaging, medical AI, MRI and other innovations.

Xing Xinhui Professor

Cooperative scientist
He mainly focuses on biochemical industry and one health. He undertook the General Program, Key Program and Major Research Plan of National Natural Science Foundation of China, international cooperation projects, the 10th Five Years Key Programs for Science and Technology Development of China, the 11th Five Years Key Projects in National Science & Technology Pillar Program, 863 Program and 973 Program. He has published more than 220 papers (including 70 in SCI and 50 in EI) and 7 co-authored books. He translated 2 textbooks, applied for more than 30 invention patents, and obtained 5 invention patents. He cooperates with E-Techco (Qianhai AnyCheck) in AI TCM and smart medical.